Transcatheter aortic valve implantation against conventional aortic valve replacement surgery in high-risk patients with aortic stenosis; a cost-effectiveness analysis
ConclusionsTAVI does not seem a cost-effective procedure in comparison with SAVR at the current willingness to pay thresholds of the country. However, by increasing the WTP threshold to 3 times the GDP per capita the probability of being cost-effective will raise to 83%.
Source: Health Economics Review - Category: International Medicine & Public Health Source Type: research
More News: Aortic Stenosis | Cardiology | Clinical Trials | Economics | Heart | Heart Valve Surgery | Insurers | International Medicine & Public Health | Iran Health | Middle East Health | Study